Dermatitis atopic
Not recruitingStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:Rocatinlimab
Poland- Participants:18–64 years · 65+ years
- Substances:Rocatinlimab
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland82 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.
Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.
Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.
These trials aim to advance treatment options for moderate to severe skin conditions.
Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.
Focus on developing targeted therapies for complex autoimmune conditions.
Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.
Research aims to improve quality of life for patients with neurological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.